Mikel Gurrea’s “Sants,” with “The Beloved” star Vicky Luengo, joins in San Sebastian’s main competition alongside Berto ...
Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, ...
Two LDS Church historians discuss the diaries of William Clayton, faith founder Joseph Smith's scribe, and what the reveals ...
The Kindle Scribe Without Front Light should be an ideal e-ink notebook, but it's limits are hard to ignore. Find out more in ...
Reader, it’s a note-taking tool too. While the recent Colorsoft range of Kindles with colour screens featured a base model, a ...
Ambient scribe developer Nabla said Brian Manning will be the Paris-based company's new CEO as it looks to grow in a highly ...
An intrepid IndieWire scribe embarks on a hero's journey to see Christopher Nolan's latest masterpiece in every possible ...
Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, is seeking to raise as much as $107.2 million in a US initial public offering.
Artificial intelligence promises much in the field of healthcare. But too much of what’s on offer is not oriented to the ...
Why this 2-year-old San Francisco company filed for an IPO © 2026 American City Business Journals. All rights reserved. Use ...